PP
ITCI
PDT Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,218
| Closed | -$2.41M | – | 845 |
|
|
2024
Q2 | $2.41M | Sell |
35,218
-15,714
| -31% | -$1.08M | 0.23% | 158 |
|
|
2024
Q1 | $3.52M | Sell |
50,932
-7,406
| -13% | -$512K | 0.33% | 83 |
|
|
2023
Q4 | $4.18M | Sell |
58,338
-12,114
| -17% | -$868K | 0.46% | 45 |
|
|
2023
Q3 | $3.67M | Buy |
70,452
+14
| +0% | +$729 | 0.46% | 45 |
|
|
2023
Q2 | $4.46M | Sell |
70,438
-9,428
| -12% | -$597K | 0.61% | 16 |
|
|
2023
Q1 | $4.32M | Buy |
79,866
+24,657
| +45% | +$1.34M | 0.59% | 7 |
|
|
2022
Q4 | $2.92M | Buy |
55,209
+41,716
| +309% | +$2.21M | 0.47% | 30 |
|
|
2022
Q3 | $628K | Buy |
+13,493
| New | +$628K | 0.1% | 365 |
|
|
2020
Q1 | – | Sell |
-6,229
| Closed | -$214K | – | 885 |
|
|
2019
Q4 | $214K | Sell |
6,229
-123,512
| -95% | -$4.24M | 0.01% | 631 |
|
|
2019
Q3 | $969K | Buy |
129,741
+84,537
| +187% | +$631K | 0.06% | 285 |
|
|
2019
Q2 | $587K | Buy |
+45,204
| New | +$587K | 0.03% | 295 |
|
|
2018
Q2 | – | Sell |
-115,700
| Closed | -$2.44M | – | 589 |
|
|
2018
Q1 | $2.44M | Sell |
115,700
-18,254
| -14% | -$384K | 0.08% | 247 |
|
|
2017
Q4 | $1.94M | Buy |
133,954
+66,154
| +98% | +$958K | 0.06% | 305 |
|
|
2017
Q3 | $1.07M | Sell |
67,800
-10,300
| -13% | -$163K | 0.04% | 348 |
|
|
2017
Q2 | $970K | Sell |
78,100
-13,084
| -14% | -$163K | 0.04% | 344 |
|
|
2017
Q1 | $1.48M | Sell |
91,184
-173
| -0.2% | -$2.81K | 0.08% | 268 |
|
|
2016
Q4 | $1.38M | Buy |
+91,357
| New | +$1.38M | 0.09% | 290 |
|